Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On June 21, 2020, Zvi Riterband resigned as Chief Executive Officer of OWC Pharmaceutical Research Corp. (the "Company").

(c) On June 21, 2020, the Company appointed Mr. Ziv Turner as Chief Executive Officer of the Company.

Ziv Turner, age 48, co-founded the Company's wholly-owned Israeli subsidiary, One World Cannabis Ltd in 2014 and served as its Chief Executive Officer until April 2, 2017. In August 2018, Mr. Turner co-founded with partners Cannibble FoodTech Ltd., a cannabis company that manufactures and sells innovative infused edibles, and serves as its Vice President of Business Development. In 2017, Mr. Turner co-founded KanaFem Ltd., a company focused on women's wellness and finding medical solutions for menopause symptoms, and serves as its Chief Executive Officer. In 2014, Mr. Turner co-founded Vocavu, a company focused on Autonomous Speech to Text technologies, and served as its Chief Technology Officer until end of 2019.

Mr. Turner, is a technology entrepreneur who focuses his time and efforts within the Cannabis industry.

Mr. Turner will receive a base salary of $10,000 per month.

(d) On June 21, 2020, the Company's Board of Directors appointed Mr. Turner to the Board of Directors.




Item 8.01 Other Events.

On April 6, 2020, Discover Growth Fund, LLC ("Discover"), a stockholder of the Company and holder of the Company's shares of Series A Preferred Stock, filed a Verified Complaint in the United States District Court Southern District of New York (the "Court") alleging that the Company's filing of its Form 15 with the Securities and Exchange Commission ("SEC") and its failure to file its Annual Report on Form 10-K for fiscal 2019 (the "Form 10-K") with the SEC was in breach of contract of the Securities Purchase Agreement and Registration Rights Agreement between the parties (the "Complaint"). The Complaint directed the Company to rescind the Form 15 and maintain its listing on the OTCQB Marketplace, and to file all SEC filings when due, including the Form 10-K.

On April 7, 2020, Discover moved for a for a preliminary injunction and on April 29, 2020, the Court entered an order that the Company must promptly, and no later than (i) May 18, 2020, engage auditors to audit the Company's Form 10-K, and to review the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 (the "10-Q") and subsequent quarterly reports; (ii) May 25, 2020, provide the Company's auditors with drafts of its 2019 annual financial statements, the 10-K, quarterly financial statements, first quarter 2020 financial information, and 10-Q; (iii) June 5, 2020, file with the SEC the 10-K and the 10-Q, and a withdrawal of the Form, and thereafter timely continue to file with the SEC all current and period reports and other filings required by OTCQB and the SEC (the "Order").

Following negotiations between the parties, on June 23, 2020, the Company and Discover filed with the Court a Stipulation Extending the Deadlines In the Order as follows: the June 5, 2020 deadline was extended until July 31, 2020 and Discover agreed not to take any action until July 31, 2020 seeking to hold the Company in contempt or to enforce the Order, or to prosecute the related and underlying claims if the Company (i) holds a special meeting of its stockholders to vote on the approval of a reverse stock split of the Company's issued and outstanding capital stock and authorizing the Company to increase its authorized capital stock, by no later than July 21, 2020, and (ii) files or otherwise makes publicly available the information required for the Form 10-K and Form 10-Q by no later than July 28, 2020.

© Edgar Online, source Glimpses